findmyKOL

Brian Madow, MD

Basic profile

Jacobs Institute

ORCIDNone on fileNPI
RegionBuffalo, NY · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Brian Madow is an Ophthalmology physician affiliated with Jacobs Institute. OpenAlex indexes 28 publications with 411 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
28publications

Distinct works indexed by OpenAlex.

411citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1176 Main St
Buffalo, NY 142092102

Telephone

716-881-7900

Provider last certified this registry record 22 Mar 2022.

View the NPPES registry record

Industry payments

11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    57.8%
    Nonsteroidal Anti-inflammatory Drug19.5%
    Bromfenac Sodium100%
    Part D47 patients
    Corticosteroid15.5%
    Prednisolone Acetate92%Ozurdex8%
    Part D<11 patients

    + 5 more classes in this area

  • Cancer & immunology

    40.1%
    Vascular Endothelial Growth Factor Inhibitor37.7%
    Eylea55%Bevacizumab42%Eylea Hd3%
    Part D + Part B<11 patients
    Complement Inhibitor2.4%
    Syfovre100%
    Part D<11 patients
  • Cardiovascular

    1%
    Beta blocker1%
    Timolol Maleate100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”